| 宫颈癌新辅助化疗32例临床分析 |
| |
| 引用本文： | 赵宁. 宫颈癌新辅助化疗32例临床分析[J]. 中国卫生产业, 2013, 0(20): 1-1,3 |
| |
| 作者姓名： | 赵宁 |
| |
| 作者单位： | 赵宁 (兖矿集团有限公司第三医院妇产科,山东济宁,272072)； |
| |
| 摘 要： | 目的分析评价以卡铂为基础的宫颈癌新辅助化疗的疗效和毒副作用。方法对该院收治的32例初治宫颈癌患者,以卡铂+5氟脲嘧啶(5-Fu)方案进行单疗程新辅助化疗。结果临床CR与PR总有效率为75%;症状缓解方面,显效率81.3%。骨髓抑制是本次化疗方案显著的毒副作用。结论 NACT是有效的;但是仍然需要进一步研究。
|
| 关 键 词： | 宫颈癌 新辅助化疗 疗效 副作用 |
Clinical observation of neoadjuvant chemotherapy based on carboplatin for 32 cases of cervical cancer |
| |
| ZHAO Ning. Clinical observation of neoadjuvant chemotherapy based on carboplatin for 32 cases of cervical cancer[J]. China Health Industry, 2013, 0(20): 1-1,3 |
| |
| Authors: | ZHAO Ning |
| |
| Affiliation: | ZHAO Ning The obstetrics and gynecology of the third Yankuang group hospital,Shandong 272072,China |
| |
| Abstract: | Objective From efficacy and safety,the carboplatin neoadjuvant chemotherapy is evaluated. Methods Our hospital has treated 32 untreated cervical cancer by single cycle of carboplatin NACT. Results The overall rate of the complete and partial response was 75%. From the aspect of Symptoms,the remarkable efficiency was 81.3%. Bone marrow suppression is the bad effects. Conclusion NACT is effective,but it needs further study. |
| |
| Keywords: | Cervical cancer NACT Efficacy Side effect |
| 本文献已被 CNKI 维普 等数据库收录！ |
